PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,734 | -16.6% | 5,958 | +8.8% | 0.00% | – |
| Q2 2023 | $219,210 | -10.5% | 5,476 | -8.7% | 0.00% | – |
| Q1 2023 | $244,833 | -59.5% | 6,000 | -61.6% | 0.00% | -100.0% |
| Q4 2022 | $603,973 | -30.4% | 15,636 | -4.4% | 0.00% | -50.0% |
| Q3 2022 | $868,000 | -5.9% | 16,355 | +3.5% | 0.00% | 0.0% |
| Q2 2022 | $922,000 | -47.6% | 15,805 | -31.6% | 0.00% | -33.3% |
| Q1 2022 | $1,761,000 | +77.3% | 23,115 | +40.2% | 0.00% | +50.0% |
| Q4 2021 | $993,000 | +181.3% | 16,490 | +161.8% | 0.00% | +100.0% |
| Q3 2021 | $353,000 | -0.3% | 6,299 | +8.8% | 0.00% | 0.0% |
| Q2 2021 | $354,000 | -13.7% | 5,790 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $410,000 | +14.2% | 5,840 | -2.4% | 0.00% | 0.0% |
| Q4 2020 | $359,000 | -2.2% | 5,984 | -2.0% | 0.00% | 0.0% |
| Q3 2020 | $367,000 | +56.8% | 6,106 | +35.2% | 0.00% | 0.0% |
| Q2 2020 | $234,000 | +73.3% | 4,516 | +12.7% | 0.00% | 0.0% |
| Q1 2020 | $135,000 | – | 4,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |